🚀 VC round data is live in beta, check it out!

Sugi Holdings Valuation Multiples

Discover revenue and EBITDA valuation multiples for Sugi Holdings and similar public comparables like Yifeng Pharmacy, Jointown Pharmaceutical, Clicks Group, CR Pharmaceutical and more.

Sugi Holdings Overview

About Sugi Holdings

Sugi Holdings Co Ltd is a Japan-based company engaged in drugstore operations and the pharmaceutical dispensing business. Through its subsidiaries, the company is involved in selling pharmaceuticals, health foods, cosmetics, daily essentials, and prescription drugs. It also operates community-based drugstores that support home healthcare in collaboration with local medical professionals. The company also supports regional healthcare facilities and provides at-home nursing services.


Founded

1982

HQ

Japan

Employees

25.9K

Sectors

Financials (LTM)

Revenue: $6B
EBITDA: $454M

EV

$4B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Sugi Holdings Financials

Sugi Holdings reported last 12-month revenue of $6B and EBITDA of $454M.

In the same LTM period, Sugi Holdings generated $2B in gross profit, $454M in EBITDA, and $279M in net income.

Revenue (LTM)


Sugi Holdings P&L

In the most recent fiscal year, Sugi Holdings reported revenue of $6B and EBITDA of $421M.

Sugi Holdings expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Sugi Holdings forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$6BXXX$6BXXXXXXXXX
Gross Profit$2BXXX$2BXXXXXXXXX
Gross Margin32%XXX28%XXXXXXXXX
EBITDA$454MXXX$421MXXXXXXXXX
EBITDA Margin7%XXX7%XXXXXXXXX
EBIT Margin5%XXX5%XXXXXXXXX
Net Profit$279MXXX$179MXXXXXXXXX
Net Margin4%XXX3%XXXXXXXXX

Financial data powered by Morningstar, Inc.

Sugi Holdings Stock Performance

Sugi Holdings has current market cap of $4B, and enterprise value of $4B.

Market Cap Evolution


Sugi Holdings' stock price is $22.44.

See Sugi Holdings trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$4B0.1%XXXXXXXXX$0.99

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Sugi Holdings Valuation Multiples

Sugi Holdings trades at 0.6x EV/Revenue multiple, and 8.8x EV/EBITDA.

See valuation multiples for Sugi Holdings and 15K+ public comps

EV / Revenue (LTM)


Sugi Holdings Financial Valuation Multiples

As of March 19, 2026, Sugi Holdings has market cap of $4B and EV of $4B.

Equity research analysts estimate Sugi Holdings' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Sugi Holdings has a P/E ratio of 14.6x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$4BXXX$4BXXXXXXXXX
EV (current)$4BXXX$4BXXXXXXXXX
EV/Revenue0.6xXXX0.7xXXXXXXXXX
EV/EBITDA8.8xXXX9.5xXXXXXXXXX
EV/EBIT12.7xXXX13.4xXXXXXXXXX
EV/Gross Profit2.0xXXX2.3xXXXXXXXXX
P/E14.6xXXX22.7xXXXXXXXXX
EV/FCF32.6xXXX58.0xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Sugi Holdings Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Sugi Holdings Margins & Growth Rates

Sugi Holdings' revenue in the last 12 month grew by 7%.

Sugi Holdings' revenue per employee in the last FY averaged $0.2M.

Sugi Holdings' rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Sugi Holdings' rule of X is 24% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Sugi Holdings and other 15K+ public comps

Sugi Holdings Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth7%XXX4%XXXXXXXXX
EBITDA Margin7%XXX7%XXXXXXXXX
EBITDA Growth7%XXX8%XXXXXXXXX
Rule of 40—XXX14%XXXXXXXXX
Bessemer Rule of X—XXX24%XXXXXXXXX
Revenue per Employee—XXX$0.2MXXXXXXXXX
Opex to Revenue—XXX24%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Sugi Holdings Public Comps

See public comps and valuation multiples for other Pharmacies comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Yifeng PharmacyXXXXXXXXXXXXXXXXXX
Jointown PharmaceuticalXXXXXXXXXXXXXXXXXX
Clicks GroupXXXXXXXXXXXXXXXXXX
CR PharmaceuticalXXXXXXXXXXXXXXXXXX
COSMOS PharmaceuticalXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Sugi Holdings M&A Activity

Sugi Holdings acquired XXX companies to date.

Last acquisition by Sugi Holdings was on XXXXXXXX, XXXXX. Sugi Holdings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Sugi Holdings

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Sugi Holdings Investment Activity

Sugi Holdings invested in XXX companies to date.

Sugi Holdings made its latest investment on XXXXXXXX, XXXXX. Sugi Holdings invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Sugi Holdings

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Sugi Holdings

When was Sugi Holdings founded?Sugi Holdings was founded in 1982.
Where is Sugi Holdings headquartered?Sugi Holdings is headquartered in Japan.
How many employees does Sugi Holdings have?As of today, Sugi Holdings has over 25K employees.
Is Sugi Holdings publicly listed?Yes, Sugi Holdings is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Sugi Holdings?Sugi Holdings trades under 7649 ticker.
When did Sugi Holdings go public?Sugi Holdings went public in 2001.
Who are competitors of Sugi Holdings?Sugi Holdings main competitors are Yifeng Pharmacy, Jointown Pharmaceutical, Clicks Group, CR Pharmaceutical.
What is the current market cap of Sugi Holdings?Sugi Holdings' current market cap is $4B.
What is the current revenue of Sugi Holdings?Sugi Holdings' last 12 months revenue is $6B.
What is the current revenue growth of Sugi Holdings?Sugi Holdings revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Sugi Holdings?Current revenue multiple of Sugi Holdings is 0.6x.
Is Sugi Holdings profitable?Yes, Sugi Holdings is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Sugi Holdings?Sugi Holdings' last 12 months EBITDA is $454M.
What is Sugi Holdings' EBITDA margin?Sugi Holdings' last 12 months EBITDA margin is 7%.
What is the current EV/EBITDA multiple of Sugi Holdings?Current EBITDA multiple of Sugi Holdings is 8.8x.
What is the current FCF of Sugi Holdings?Sugi Holdings' last 12 months FCF is $122M.
What is Sugi Holdings' FCF margin?Sugi Holdings' last 12 months FCF margin is 2%.
What is the current EV/FCF multiple of Sugi Holdings?Current FCF multiple of Sugi Holdings is 32.6x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial